Key People

TMC is a full service organisation with a difference

TMC was created in 2001 as The Matthews Consultancy (hence TMC). Since then, we've grown steadily in geographical reach and scope of activities to become TMC Pharma Services - a full-service organisation with a difference.

We do this by putting together hand-picked teams of specialists in the countries where they are needed, drawing on our extensive network of tried and trusted Associates across all disciplines. This approach combines flexibility and specificity, benefiting the client by matching resources exactly to the project's needs.

Julie Matthews - Chief Executive Officer and VP Operations

Trained in microbiology, Julie ran an academic hospital research laboratory in Cambridge
(UK) prior to joining Warner Lambert Clinical Development Group in 1986, where she ultimately became International
Therapy Area Director. She then joined Rhone Poulenc Rorer in France, where she was involved first in oncology
clinical development, and subsequently as Head of Anti-infectives Clinical Development.

Julie then joined Orphan Europe in Paris as Head of Clinical Development and Regional Business Manager,
before going on to set up and run the company's UK affiliate, as General Manager responsible for drug and business
development, regulatory affairs, sales and marketing.

Julie started TMC in the year 2000.

Dr Mike Matthews MB ChB - Chief Medical Officer

After taking his medical degree at the University of Birmingham (UK) Mike worked in the UK Health
and Safety Executive in infection control in hospitals and research labs, before joining the pharmaceutical industry
in 1986.

Since then, Mike has worked with ICI Pharmaceuticals HQ (now AstraZeneca) in the UK; Adelphi Communications (UK);
Sanofi Recherche HQ (France); ADIS International (UK); ICON Clinical Research (as Director of Medical Affairs, Europe,
based in the UK).

Mike has also acted as an independent consultant to both major pharmaceutical and niche biotech companies.

Mike joined TMC in 2001.

Nicola Kidman - Vice President of Regulatory Services

After graduating from The University of Reading (UK) in 1999 with a degree in Pathobiology, Nicola
joined Aventis Pharma where she was responsible for regulatory management of a portfolio products registered via
national, mutual recognition and centralised procedures.

In 2004, Nicola moved to Orion Clinical Services as Regulatory Affairs Manager and then in late 2005 to Parexel
Consulting, the regulatory consulting division of Parexel International Ltd. During her time at Parexel she held a
number of roles, including management of the UK Clinical Trial Regulatory Team and later responsibility for the UK
Consulting team of approximately 30 staff providing European and Worldwide regulatory consulting covering all aspects
of drug development.

Nicola Joined TMC in March 2011.

Sarah Blondell - Vice President of Clinical Services

With her MSc degree in Clinical Pharmacology from the University of Aberdeen, Sarah commenced her
industry career in 1994, as a Clinical Research Associate at Boots Pharmaceuticals. She continued her career in clinical
monitoring at Lundbeck, specialising in Neuroscience and then moved into clinical team management at CroMedica Inc, in
Canada.

Sarah’s extensive global Program Management experience began at i3 Research in 2005, where she also developed her
expertise in Pediatric clinical trials.

In 2010 Sarah joined Quintiles, as a Senior Director, responsible for the management of Project Directors, Portfolio
Oversight and ultimately the Therapeutic Strategy Lead for Psychiatry.

Sarah is a Chartered Scientist and a Member of the Institute of Biomedical Sciences and joined TMC in 2014.

Kieran O'Donnell - Vice President of Pharmacovigilance Services

After graduating in 1999 with an MSc Exercise & Human Physiology, specialising in the Metabolic
Syndrome, Kieran has spent over 14 years in drug safety with experience not only in both small and large pharmaceutical
companies; but also in CROs and PV consultancy.

In addition to the completion of a PgC Pharmacovigilance from the University of Hertfordshire, Kieran is a member of
the several industry associations, and has been a member of the BARQA PV Committee since the beginning of 2008.

Kieran joined TMC in June 2014.

Dr Tomasz Knurowski MD - Vice President of Medical Services

After qualifying as a Medical Doctor in 1998 in Krakow, Tomasz gained broad clinical experience in
Poland. He was also involved for several years in academic research (including epidemiology), as well as working as a
Medical Scientific Liaison in Poland.

Since then, Tomasz has worked for more than ten years in the pharmaceutical industry in the UK, in pharmaceutical
companies and CROs. He is qualified as a specialist Pharmaceutical physician, Member of the UK Faculty of Pharmaceutical
Physicians. Tomasz has extensive medical monitoring experience on a variety of challenging projects across all phases of
development in diverse indications (notably oncology, rare diseases and auto-immune conditions). He has in-depth
pharmacovigilance experience (pre- and post-marketing) including acting as EU Deputy QPPV.

Tomasz joined TMC in Dec 2016.

Dr Andrew Law MB ChB - Director of Medical Services

After qualifying as a Medical Doctor in 2004 from Bristol University (UK), Andrew gained broad
clinical experience throughout the UK and Australia.

Andrew joined the pharmaceutical industry in 2011 and has focused on medical affairs, including leading life-cycle
medico-marketing/market access activities. This includes product and device launches within rare disease therapy areas.

Andrew is also a Member of the Faculty of Pharmaceutical Physicians.

Andrew joined TMC in Jan 2017.

Prabjot Hunjan - Director of Pharmacovigilance Services

Prabjot graduated in 1999 with a BSc (Hons) in Pharmaceutical Science from the University of Kingston
(Surrey, UK). Following his graduation, Prabjot spent 6 years in management within a leading UK ophthalmology chain,
following which his experience has primarily been within drug safety and CROs over the past 10 years.

In addition, Prabjot completed a PgC in Pharmaceutical Medicine from the University of Surrey.

Prabjot joined TMC in November 2016.

Dr Clare Halcro BM BS - Clinical Research Physician

Clare graduated Peninsula College of Medicine & Dentistry with a medical degree in 2010. She spent 2
years working within the NHS completing her foundation training. During this time she developed an interest in drug
safety and became a member of the Patient Medication Safety Group.

Clare continued her career in clinical medicine in Australia where she practised within general and emergency
medicine.

Clare pursued her interest in drug safety and joined TMC in 2014 and subsequently enrolled in the Pharmaceutical
Medicine Specialty Training. In her role at TMC she provides medical monitoring services, particularly in the
pharmacovigilance sphere, and medical input to company projects.

Catherine Moncad - Director of Regulatory Services

Catherine has a degree in Biochemistry and Biology. In 1998 she joined PAREXEL as a Clinical Data Manager,
in 2001 she joined Reckitt Benckiser within R&D /Clinical Affairs and then Regulatory Affairs with OTC products/MAAs/worldwide
lifecycle maintenance.

Catherine gained further regulatory experience in generics and medical devices at Dr Reddy’s Laboratories and Smith &
Nephew, before joining Chiltern in 2008 where her focus was clinical trials. In 2012 Catherine joined PRA as Director of Global
Regulatory Affairs; she led a team of over 60 people in the UK, Ukraine, Russia and Georgia and was also involved in process
improvement.

Catherine joined TMC in March 2017

Damien Mair - Company Portfolio Director

Damien has a BSc (Hons) from the University of Wales (2005), and began his industry career as a Research
Technician / Study Coordinator in Phase I. He joined Guys Drug Research Unit (GDRU; Quintiles) in late 2006 before moving to
PAREXEL’s quality department, where he gained valuable experience in a management role.

In 2010, Damien joined INC Research, in Customer Relations, then Operations Management, after a short time he was given
responsibility for global oversight of a team across multiple regions, managing direct reports in North America (US), Europe
(UK), and Asia Pacific (Japan, Singapore and Australia). At the same time, he also achieved his MSc from Napier University,
Edinburgh.

Damien joined TMC in 2017.

Paul Carrodus - Associate Director of Regulatory Services

Paul graduated from The University of Reading (UK) in 2002 with a degree in Biological Sciences.

Paul’s first job in the industry was with Orion Clinical Services, joining as Medical Writer before transitioning
into the position of Regulatory Associate managing European clinical trial applications.

Paul joined Abbott Laboratories (now AbbVie) in 2010 and as Senior Regulatory Manager developed and implemented
European regulatory strategies for development compounds and marketed products, which included submission of the company’s
first European orphan MAA in oncology via the centralised procedure.

Paul joined TMC in March 2016.

Georgina Keep - Project Leader

George graduated from the University of Bristol with BSc (Hons) in Biology in 1997 and soon joined
Parexel International as a Clinical Research Associate where she gained a thorough grounding in clinical development.
She subsequently joined Wyeth in 2001, and rose through the Project Management ranks to Global Trials Leader, obtaining
a thorough knowledge and understanding of the drug development process; from Phase 1 through to Phase IV. She also
attained good leadership skills during her 9 years with Wyeth, through line management of other project managers and
support staff.

George has over 15 years Pharma industry experience and started working with the TMC team in 2011.

Preti Patel - Senior Pharmacovigilance Scientist

Preti graduated with a degree in BSc Pharmacology from University of Portsmouth in 2002. She gained
further clinical research experience at AstraZeneca primarily working on high profile oncology studies.

Preti has over 7 years of Pharmacovigilance experience and has gained broad experience in clinical and post marketing
pharmacovigilance including case processing, signal detection, risk management plans, coordination and/or authoring of
aggregate reports. More recently in Eisai where she was a product specialist involved in overseeing safety operations
for oncology products.

Preti is a member of several industry associations and joined TMC in July 2015.

Gina Cernuschi - Finance Controller

Gina studied and trained in administration and secretarial skills before working in a number of
companies, including Black & Decker and Rockwell Collins, as Personal Assistant to the senior managers.

Gina brings a broad skill set and lots of enthusiasm to her position, she has been managing TMC’s finance department
since 2005 and is responsible for all TMC’s routine financial matters, including invoicing and payments.

Kim Andrews - Projects Administrator

After graduating the University of Winchester in 2008 with a degree in Media Studies and Film, Kim
joined the hospitality industry working on a busy reception for the De Vere group.

Kim continued developing her strong reception and administration career when working for a large asset management
company in 2011. After learning several administration skills in a large corporate firm Kim moved into an office management
role for a financial services company in 2013.

Kim joined TMC in March 2015 as a projects administrator with a strong front of house presence at the TMC office.